| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 May 2025 | 19 May 2025 |
| Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve approval of Audited financial results of the company along with audit report for the quarter and year ended on 31.03.2025 Outcome of Board Meeting for approval of Audited financial results of the company along with the Statutory Audit Report and Declaration as per Regulation 33 of SEBI (LODR) Regulations, 2015, for the quarter and financial year ended 31.03.2025 and appointment of secretarial auditor, appointment of independent director and resignation of independent director and reconstitution of committees of the board (As Per BSE Announcement Dated on :26.05.2025) | ||
| Board Meeting | 1 Apr 2025 | 1 Apr 2025 |
| Outcome of Board meeting held on 01.04.2025 | ||
| Board Meeting | 12 Feb 2025 | 7 Feb 2025 |
| Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the un-audited financials of the company for the quarter ended 31-12-2024 OUTCOME OF BOARD MEETING FOR APPROVAL OF UN-AUDITED FINANCIALS OF THE COMPANY FOR THE QUARTER NEDED 31-12-2024 (As Per BSE Announcement dated on 12.02.2025) | ||
| Board Meeting | 13 Nov 2024 | 4 Nov 2024 |
| Ortin Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Un-audited Financial Results for the quarter and Half year ended 30.09.2024 outcome of board meeting held on 13-11-2024 for approval of un-audited financials for the quarter ended on 30-09-2024 (As Per BSE Announcement dated on 13.11.2024) | ||
| Board Meeting | 25 Sep 2024 | 25 Sep 2024 |
| Outcome of Board Meeting | ||
| Board Meeting | 13 Aug 2024 | 6 Aug 2024 |
| Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. Un-audited Financial Results for the quarter ended 30.06.2024 2. Limited Review Report for the quarter ended 30.06.2024. 3. To consider induction of new Directors in the Company. 4. To take note on the resignation of Mrs. Divya Purswani as company secretary & Compliance officer of the company. 5. Any other business with the permission of the Chair Un-Audited Financial Results for the Quarter ended 30-06-2024 (As Per Bse Announcement Dated on 13.08.2024) | ||
| Board Meeting | 31 Jul 2024 | 24 Jul 2024 |
| Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 inter alia to consider and approve 1. Induction of new Directors in the Company. 2. To take note on the resignation of Mrs. Divya Purswani as company secretary & Compliance officer of the company. 3. Any other business with the permission of the Chair. Postponement of Board meeting scheduled to be held on 31.07.2024 (As Per BSE Announcement Dated on: 31/07/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.